Clinical Trial Update: INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP) [Phase 1, Phase 2]

View source ↗

Summary

Completion of a Phase 1/2 clinical trial evaluating INO-3107 with electroporation in patients with HPV-6/11-associated recurrent respiratory papillomatosis, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Papillomatosis

Drugs mentioned

• INO-3107 (INO-3107)

Snippet

Sponsor: Inovio Pharmaceuticals | Conditions: Respiratory Papillomatosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-04-14